KalVista Pharmaceuticals任命Jeb Ledell为首席运营官

• KalVista Pharmaceuticals (NASDAQ:KALV) announces the appointment of Jeb Ledell as COO.
• Most recently, Ledell served as COO at AVEO Oncology, an LG Chem company.
• Furthermore, Ledell was granted inducement options to purchase 100,000 shares of the company's common stock on December 16, 2024, as an inducement to his employment with KalVista. The options will have an exercise price equal to the closing price on the Nasdaq Stock Market LLC on the grant date. The options will vest over a four-year period, with each option having a 10-year term.
• KALV stock price traded 7.94% lower on Tuesday during pre-market hours of trading.

More on KalVista Pharmaceticals

• KalVista: Upcoming PDUFA, But Not Without Risks
• KalVista prices $55M stock offering
• Seeking Alpha’s Quant Rating on KalVista Pharmaceticals
• Historical earnings data for KalVista Pharmaceticals
• Financial information for KalVista Pharmaceticals